MENTOR CAPITAL, INC. (OTCMKTS:MNTR) Files An 8-K Entry into a Material Definitive Agreement

0

MENTOR CAPITAL, INC. (OTCMKTS:MNTR) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01

Entry into a Material Definitive Agreement.

On March 22, 2017 the registrant entered into a series of transactions with G FarmaLabs Limited, a Nevada corporation, and certain of its Affiliates (collectively “G Farma”).  Under the transactions the registrant entered into (i) a Notes Purchase Agreement with G Farma to which the registrant bought an aggregate of $500,000 in initial principal face amount of promissory notes from G Farma (the “Notes”), (ii) certain agreements designed to secure repayment by G Farma of the Notes, (iii) a Consulting Agreement with G Farma, (vi) a Rights Agreement to which G Farma granted the registrant certain rights, and (v) a Subscription Agreement to which the registrant sold G Farma 222,223 shares of its common stock at a price per share of $2.25.  

The sales of stock by the registrant was made in reliance upon Rule 506 of Regulation D and Section 4(2) of the Securities Act of 1933, as amended (the “Act”) and such securities have not been registered and will not be registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.  This current report is neither an offer to sell, nor a solicitation of offers to purchase, securities.


About MENTOR CAPITAL, INC. (OTCMKTS:MNTR)

Mentor Capital Inc is a United States-based firm that invests in medical marijuana and recreational use cannabis companies. The Firm has $140 million capital structure and looks like a marijuana fund or cannabis index fund. Its preferred focus is medical and the Company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing ocular pressures from glaucoma and blunting chronic pain. Its portfolio includes Agenus, Inc, Brighter Day Health, CannaVest, Cel Sci Corp, TBA, Pfizer, Inc, Vical and WCI INC, among others. Effective March 11, 2014, Mentor Capital Inc acquired a 60% interest in Bhang Chocolate Co Inc, a producer of medicated chocolate bars.

MENTOR CAPITAL, INC. (OTCMKTS:MNTR) Recent Trading Information

MENTOR CAPITAL, INC. (OTCMKTS:MNTR) closed its last trading session up +0.04 at 2.44 with 235,037 shares trading hands.